(19)
(11) EP 2 486 916 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
27.03.2013 Bulletin 2013/13

(88) Date of publication A3:
15.08.2012 Bulletin 2012/33

(43) Date of publication:
15.08.2012 Bulletin 2012/33

(21) Application number: 11010051.8

(22) Date of filing: 13.12.2007
(51) International Patent Classification (IPC): 
A61K 9/10(2006.01)
A61K 47/48(2006.01)
A61K 38/27(2006.01)
C07K 14/61(2006.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 18.12.2006 US 870605 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
07869230.8 / 2120869

(71) Applicant: Althea Technologies, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • Bush, Lawrence
    Seattle, Washington 98103 (US)
  • Pechenov, Sergey
    Malden, Massachusetts 02148 (US)
  • Basu, Sujit K
    Newton, Massachusetts 02459 (US)

(74) Representative: Graf von Stosch, Andreas et al
Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München
80538 München (DE)

 
Remarks:
This application was filed on 21-12-2011 as a divisional application to the application mentioned under INID code 62.
Remarks:
Claims 16-29, 31-84, 86-94, 96-98, 100-125 are deemed to be abandoned due to non-payment of the claims fees (Rule 45(3) EPC).
 


(54) Human growth hormone formulations


(57) Formulations containing complexed human growth hormone crystals are described. Also described are needleless injection systems for crystalline proteins.